Showing results (1731-1740 of 2,993) with videos related to

Sort By:
Pageof 300
Urologic Oncology|March 4, 2020
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinomaGiuseppe Rosiello, Carlotta Palumbo, Sophie Knipper, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 22, 2013
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladderE Xylinas, B D Robinson, L A Kluth, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 15, 2011
Tissue-based molecular markers for renal cell carcinomaM Rink, F K H Chun, B Robinson, et al.
Urology|August 14, 2017
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter StudyIngmar Wolff, Anna Scavuzzo, Umberto Capitanio, et al.
Translational Andrology and Urology|October 28, 2016
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?Paul Sargos, Brian C Baumann, Libni J Eapen, et al.
European Urology Oncology|August 15, 2019
The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative OutcomesElio Mazzone, Felix Preisser, Sebastiano Nazzani, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2016
Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare databaseJonas Schiffmann, Maxine Sun, Giorgio Gandaglia, et al.
European Urology Focus|March 19, 2021
Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical NephroureterectomyClaudia Collà Ruvolo, Luigi Nocera, L Franziska Stolzenbach, et al.
Immunotherapy|July 6, 2023
Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku, et al.
The Journal of Urology|May 22, 2026
First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysisKeiichiro Miyajima, Marcin Miszczyk, Akihiro Matsukawa, et al.
Pageof 300